| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0784973A2 Quinoxaline derivatives for treating tinnitus |
| 07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 07/23/1997 | EP0451194B1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/22/1997 | US5650429 Use of DL-(+/-)-α-lipoic acid, D-(+)-α-lipoic acid, α-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders |
| 07/22/1997 | US5650414 Pyrazolopyridines or imidazolopyridines |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/16/1997 | EP0783503A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO 1,2-a]PYRAZINE DERIVATIVES |
| 07/16/1997 | EP0726903B1 Matrix metalloprotease inhibitors |
| 07/15/1997 | US5648492 Process for preparing isoquinoline compounds |
| 07/10/1997 | WO1997024348A1 ((3'-thioxacyclohex-1'-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/10/1997 | WO1997024334A1 Benzimidazole derivatives |
| 07/10/1997 | WO1997024128A1 Otic microbial combinations |
| 07/10/1997 | WO1997024123A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | WO1997009049A3 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 07/10/1997 | CA2241913A1 Use of polyamine site antagonist for the manufacture of a medicament for the treatment of ischemic disorders of the eye |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2240401A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
| 07/09/1997 | EP0782571A1 Compositions and methods for treating mast-cell inflammatory condition |
| 07/09/1997 | EP0782454A1 Use of muramyl peptide compounds |
| 07/09/1997 | EP0782448A1 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| 07/09/1997 | EP0782447A1 Method and means for prevention and treatment of secondary cataract |
| 07/09/1997 | EP0782444A1 Method of inhibiting conditions associated with bradykinin |
| 07/09/1997 | EP0720602B1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 07/08/1997 | US5646289 Reacting a 3-chloro-1,2,5-thiadiazole with alkali metal bis(trialkyl or arylsilyl)amide; dechlorination; treating nervous system disorders |
| 07/08/1997 | US5646144 For treating disorders in which substance p plays a part in development |
| 07/08/1997 | US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 07/08/1997 | CA2057913C N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 07/03/1997 | WO1997023510A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023482A1 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives |
| 07/03/1997 | WO1997023480A1 Novel integrin receptor antagonists |
| 07/03/1997 | WO1997023465A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023223A1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 07/03/1997 | WO1997023222A1 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
| 07/03/1997 | CA2240439A1 Novel integrin receptor antagonists |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/02/1997 | EP0781547A1 Sodium hyaluronate based ophthalmic formulation for use in eye surgery |
| 07/02/1997 | EP0781277A1 Neurokinin antagonists |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643943 Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis |
| 07/01/1997 | US5643879 Oligopeptide enzyme inhibitors as hypotensive agents |
| 07/01/1997 | CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 06/26/1997 | WO1997022587A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/26/1997 | DE19548624A1 Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New barbituric acid derivatives, processes for their preparation and medicaments containing these compounds |
| 06/25/1997 | EP0780386A1 Matrix metalloprotease inhibitors |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152876A Laerimal gland specific emulsions for topical application to ocular tissue |
| 06/24/1997 | US5641805 Topical ophthalmic formulations for treating allergic eye diseases |
| 06/24/1997 | US5641800 Alleviate effect of septic shock, adult respiratory distress syndrome, pancreatitis, trauma, bronchial asthma, allergic rhinitis, and rheumatoid arthritis |
| 06/24/1997 | US5641781 Topical ophthalmic composition comprising a 2-[4-(azolylbutyl)piperazinylmethyl]benzimidazole derivative, in particular for the treatment of allergic conjunctivitis |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641756 Synthetic oligonucleotide complementary to nucleic acid specific for human vascular endothelial growth factor |
| 06/24/1997 | US5641750 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| 06/24/1997 | US5641749 Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product |
| 06/19/1997 | WO1997021665A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors |
| 06/18/1997 | EP0779291A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/18/1997 | EP0778848A1 Agents for inducing apoptosis and applications of said agents in therapy |
| 06/18/1997 | EP0778733A1 A basic protein composition for killing or inhibiting microbial cells |
| 06/17/1997 | US5639746 Inhibitors of metalloprotease |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/12/1997 | CA2192281A1 Heterocyclylcarbonyl substituted benzofuranyl-ureas |
| 06/11/1997 | EP0777729A1 5-lipoxygenase-activating protein ii |
| 06/11/1997 | EP0777686A1 Trophic factors for central nervous system regeneration |
| 06/11/1997 | EP0777680A1 Urokinase receptor ligands |
| 06/11/1997 | EP0777483A1 Methods and means for drug administration |
| 06/11/1997 | EP0777482A1 Combined preparation for the therapy of immune diseases |
| 06/11/1997 | EP0777480A1 Optic nerve health |
| 06/11/1997 | EP0777471A1 Inhibition of leukotriene biosynthesis with urea derivatives |
| 06/10/1997 | US5637712 Process of preparing isoquinoline compounds |
| 06/10/1997 | US5637604 Treatment and control of ocular development |
| 06/10/1997 | CA2040460C Drug delivery with thermoreversible gels |
| 06/05/1997 | WO1997019942A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
| 06/05/1997 | WO1997019695A1 Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/05/1997 | WO1997019694A1 Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 06/04/1997 | EP0776885A1 Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses |
| 06/04/1997 | EP0776881A1 Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization |